Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, a system was developed utilizing advanced image processing to analyze hair and scalp conditions, aiding professionals in diagnosing diseases like alopecia and monitoring treatment by extracting and comparing key parameters from microscopic images.

The abstract notes that while telogen effluvium—a condition causing diffuse hair loss—is triggered by stressors like significant weight loss, there is limited literature specifically exploring the connection between telogen effluvium and weight loss.

In this study, researchers reviewed the evidence linking COVID-19 with dermatologic conditions like androgenetic alopecia and concluded that most proposed associations lack convincing statistical support, challenging the idea of these as independent risk factors for COVID-19 severity.

This study found that a 12-week topical treatment with a caffeine and Procapil 3% formulation effectively reduced hair loss by 26.9% and improved hair growth in men with androgenetic alopecia, without any reported adverse effects.

This study developed and validated the Hair-Shedding Visual Scale for Asian Women, finding it to be an effective tool for identifying FPHL and TE.

This review examines the anatomy and physiology of hair, focusing on the hair growth cycle and various types of alopecia, using animal models such as mice and rats to study the condition's pathophysiology and aid in developing new treatments.

This systematic review concluded that mesotherapy shows potential for improving hair growth outcomes, yet lacks standardized regimens and requires further large-scale trials to establish its efficacy and safe use.

This study observed that female patients with chronic telogen effluvium had significantly lower levels of total thiol, thiol-disulphide, and disulphide compared to healthy controls, indicating a disruption in oxidative stress balance.

This study found that autophagy activation in hair follicle stem cells shifted their metabolism to glycolysis, which promoted hair growth by initiating the hair follicle cycle.

This study reviewed data from three hospitals and found that alopecia after DRESS occurred more often in severe cases, but the rate of corticosteroid treatment did not significantly differ between patients with and without alopecia.

This study found that both trichoscopy and folliscopy are highly accurate for diagnosing telogen effluvium, but trichoscopy is easier and quicker to perform.

In this study, serum zinc levels in telogen effluvium patients showed no significant difference compared to healthy controls.

This study found that histopathologic features such as a catagen/telogen shift, melanin in fibrous tracts, and small dystrophic follicles can help differentiate alopecia areata from pattern hair loss in the absence of peribulbar infiltrates.

This study found that both trichoscopy and folliscopy are highly accurate for diagnosing telogen effluvium, though trichoscopy is simpler and faster to perform.

This study found that HtrA2 inactivation in mnd2 mice is associated with delayed hair cycle phases and growth retardation of adipocytes, suggesting HtrA2's role in regulating adipogenesis-related hair growth.

This chapter reviews the basic physiology and causal mechanisms of hair follicle disorders, but it reports no new clinical results.

COVID-19 can cause temporary hair loss in some people.

This review discusses the complex nature of telogen effluvium linked to COVID-19 and highlights the effectiveness of correcting triggers and protein-rich diets in reducing hair loss; it reports no new clinical findings.

Hair loss can be caused by hormones, illness, autoimmune disorders, or vitamin deficiencies, and treatments vary depending on the type.

This article reviews various factors contributing to telogen effluvium and examines potential treatments like Minoxidil, but reports no new clinical findings.

This chapter reviews various hair disorders, focusing on androgenetic and scarring alopecias, and discusses management strategies, but presents no new research findings.

This review discusses the causes, diagnosis, and treatment approaches for telogen effluvium but presents no new clinical findings; novel treatments like ALRV5XR are highlighted as promising.

This study found that topical resveratrol significantly promotes hair growth in mice and may protect human dermal papilla cells from oxidative damage, suggesting its potential as a treatment for hair loss.

This study highlights that stress-induced activation of the HPA axis in human hair follicles can lead to hair growth arrest, but variability in follicle response complicates potential therapeutic approaches.

This article discusses hair loss conditions and treatments, including the use of finasteride in male androgenetic alopecia and its variable results in women, without presenting new clinical findings.

This study found that trichoscopy is a valuable diagnostic tool for identifying hair loss patterns in women and can help avoid scalp biopsies in unclear cases.

This article reviews the phases of hair growth and differences between androgenetic alopecia and telogen effluvium but provides no new clinical findings on Electric Follicle Stimulation.

This review discusses telogen effluvium in women and suggests that combining minoxidil with supplementary therapies may enhance treatment outcomes, but it reports no new clinical results.

In this study, women with diffuse hair loss reported that Proteoglycan Replacement Therapy with Nourkrin® improved hair growth and appearance, boosting their confidence and satisfaction with the treatment.

This article discusses the role of trichology in treating hair and scalp conditions by addressing underlying body systems and reports no new clinical findings.